ArticleVeterinary research2025
Mechanisms of vaccine protection in chickens against challenge with virulent Mycoplasma synoviae.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Vaxsafe MS vaccine is used globally to control infections with Mycoplasma synoviae (MS) in commercial poultry. It provides long-term protective immunity against airsacculitis and tracheitis caused by M. synoviae. However, the mechanisms involved in the protection afforded by the vaccine are not well understood. This study aimed to investigate and compare tracheal mucosal responses to challenge with virulent M. synoviae in chickens vaccinated with Vaxsafe MS and in unvaccinated chickens. The tracheal mucosal transcriptional profiles were obtained using messenger RNA sequencing. Compared to the unvaccinated-unchallenged chickens, 64 genes were differentially transcribed in the vaccinated-challenged chickens and 321 genes were differentially transcribed in the unvaccinated-challenged chickens. In vaccinated-challenged chickens, functional categories enriched with up-regulated genes included IL4 production, TCR signalling (without T-cell co-stimulation), T-cell activation/proliferation/differentiation and B-cell activation/proliferation. In the unvaccinated-challenged chickens, many other functional categories were also enriched with upregulated genes, including Positive regulation of the MAPK/ERK cascades, Positive regulation of IFN gamma production, T-cell co-stimulation, Negative regulation of IL6 production, IL10 production, Toll-like receptor signalling, Neutrophil activation/degranulation, DAP12 signalling, Chemotaxis, Phagocytosis, Cell killing, PD-1 signalling, Negative regulation of non-canonical NF-κB signal transduction, Isotype switching and Somatic diversification of immune receptors. The transcriptional changes in the unvaccinated-challenged chickens were indicative of T-helper-1-cell-mediated inflammation and dysregulated primary T- and B-cell responses, which were absent in the vaccinated-challenged chickens. In the vaccinated-challenged chickens the changes were indicative of a memory T-follicular-helper-cell-dependent secondary B-cell response, suggesting that this response was protective against the dysregulated inflammatory response seen in unvaccinated chickens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.